Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Reproducing human and cross-species drug toxicities using a Liver-Chip | Science Translational Medicine
Reproducing human and cross-species drug toxicities using a Liver-Chip | Science Translational Medicine
Signaling cascades in the failing heart and emerging therapeutic strategies | Signal Transduction and Targeted Therapy
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
JPM | Free Full-Text | Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer's Disease
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Tracleer, INN- bosentan"
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
Endothelin‐1 in the pathophysiology of obesity and insulin resistance - Jenkins - 2020 - Obesity Reviews - Wiley Online Library
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
Frontiers | Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
Development of macitentan for the treatment of pulmonary arterial hypertension - Selej - 2015 - Annals of the New York Academy of Sciences - Wiley Online Library
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
CXCL10, a SSc Driver of Inflammation Lowered With Iloprost: Study| Scleroderma News
Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis - John W. McConnell, Yuen Tsang, Janis Pruett, William Drake
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine
NEW ZEALAND DATA SHEET TRACLEER®
NEW ZEALAND DATA SHEET TRACLEER®
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction | Journal of Medicinal Chemistry
Development of macitentan for the treatment of pulmonary arterial hypertension - Selej - 2015 - Annals of the New York Academy of Sciences - Wiley Online Library
Relationship between ET-1 and RAS. Bosentan treatment increased the... | Download Scientific Diagram
PatHligHt
Effects of bosentan, an edothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2 | Request PDF
Janssen CarePath for Healthcare Professionals
